BEGIN:VCALENDAR
BEGIN:VEVENT
DTSTART:20250320T160000Z
DTEND:20250320T170000Z
SUMMARY:2024-25 Health Sciences Seminar Series - Dr. Jean-Simon Diallo
DESCRIPTION:The Department of Health Sciences is pleased to announce the next seminar in our 2024-25 Health Sciences Seminar Series, and this event will be held in-person, with a virtual option via Zoom.


Zoom Registration

In-person Registration


 



Overcoming the Many Hurdles to Making Therapies Viral



TurretPosition="TurretPosition1" ObjectiveLens="4x" FilterCube="GFP" CaptureMode="FindAndFocus" LightingSetting="30%" ExposureUs="750000" CaptureSoftware="EVOS Software Revision 26059"



Abstract



Viruses, once the cause of devastating diseases, are now powerful tools in combating illness, serving as vaccines and treatments for genetic diseases and cancer through advanced genetic engineering. Among these, oncolytic viruses hold significant promise but face challenges such as clinical resistance and manufacturing bottlenecks. Biomanufacturing remains a critical obstacle for all virus-based therapies. Dr. Diallo and his team have been at the forefront of developing small molecules to overcome these barriers, enhancing the effectiveness of oncolytic viruses and improving the production of viral vectors and vaccines. Their decade-long research has not only driven innovative commercial applications but also provided valuable insights into antiviral defense mechanisms, paving the way for more effective viral therapies.



Presenter











 



Dr. Jean-Simon Diallo
Senior Scientist, Ottawa Hospital Research Institute, Cancer Research Program
Assistant Professor, University of Ottawa, Faculty of Medicine, Department of Biochemistry, Microbiology and Immunology
Chief Executive Officer, Virica Biotech.
LOCATION:4040 Nicol, Carleton University, 1125 Colonel By Dr, Ottawa, ON K1S 5B6
URL:
END:VEVENT
END:VCALENDAR